FSPKF OTC
Fisher & Paykel Healthcare Corporation Limited
1W: +1.6%
1M: -2.0%
3M: +15.5%
YTD: +35.0%
1Y: +24.9%
3Y: +114.8%
5Y: +23.9%
$26.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$2.9B
+13.0% ▲
5Y CAGR: +6.8%
Total Liabilities
$746M
+12.9% ▲
5Y CAGR: +6.1%
Shareholders Equity
$2.1B
+13.0% ▲
5Y CAGR: +7.0%
Cash & Investments
$466M
+76.1% ▲
5Y CAGR: +4.3%
Total Debt
$146M
-4.7% ▼
5Y CAGR: +4.3%
Net Debt
-$320M
-187.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $90M | $121M | $82M | $264M | $466M |
| Short-Term Investments | $200M | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $290M | $121M | $82M | $264M | $466M |
| Net Receivables | $174M | $218M | $257M | $305M | $346M |
| Inventory | $359M | $366M | $320M | $343M | $331M |
| Other Current Assets | $65M | $69M | $45M | $23M | $21M |
| Total Current Assets | $888M | $774M | $705M | $935M | $1.2B |
| Property, Plant & Equip. | $958M | $1.1B | $1.3B | $1.3B | $1.4B |
| Goodwill & Intangibles | $87M | $86M | $88M | $82M | $73M |
| Long-Term Investments | $91M | $100M | $0 | $0 | $49M |
| Other Non-Current Assets | $0 | $0 | $56M | $40M | $0 |
| Total Non-Current Assets | $1.2B | $1.4B | $1.6B | $1.6B | $1.7B |
| Total Assets | $2.1B | $2.2B | $2.3B | $2.6B | $2.9B |
| — Liabilities — | |||||
| Accounts Payable | $54M | $43M | $32M | $53M | $57M |
| Short-Term Debt | $5M | $4M | $78M | $64M | $7M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $61M | $49M | $69M | $142M | $197M |
| Total Current Liabilities | $304M | $290M | $385M | $500M | $503M |
| Long-Term Debt | $63M | $79M | $36M | $0 | $52M |
| Other Non-Current Liab. | $36M | $34M | $39M | $84M | $119M |
| Total Non-Current Liabilities | $123M | $161M | $138M | $160M | $243M |
| Total Liabilities | $427M | $451M | $523M | $660M | $746M |
| — Equity — | |||||
| Common Stock | $261M | $304M | $409M | $469M | $503M |
| Retained Earnings | $1.2B | $1.2B | $1.1B | $1.2B | $1.5B |
| Accumulated OCI | $237M | $249M | $260M | $195M | $182M |
| Total Stockholders Equity | $1.7B | $1.8B | $1.8B | $1.9B | $2.1B |
| Total Liabilities & Equity | $2.1B | $2.2B | $2.3B | $2.6B | $2.9B |
| — Key Metrics — | |||||
| Total Debt | $104M | $146M | $189M | $153M | $146M |
| Net Debt | $14M | $25M | $107M | -$111M | -$320M |
| Total Investments | $291M | $100M | $0 | $0 | $49M |